Crypto Mogul Flies to Space Aboard Latest Blue Origin Flight
The flight lifted off Sunday at 7:42 a.m. local time from West Texas on a short suborbital joyride to space.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
Columbia University Libraries Modernize Library Infrastructure with EBSCO FOLIO
~ Leading Academic Institution Transitions from Legacy Systems to a Unified Open Platform to Improve Access, Insights and Service Delivery ~ IPSWICH, Mass., Aug. 6, 2025 /PRNewswire-PRWeb/ -- The Columbia University Libraries have officially gone live with FOLIO, replacing multiple legacy systems with a single, unified platform. Backed by the EBSCO FOLIO team at EBSCO Information Services (EBSCO), the transition to an open-source system aims to address evolving research needs and simplify library services through a single, interoperable solution. FOLIO allows Columbia Libraries to manage resources more flexibly while integrating with essential tools, including the Libraries' Blacklight-based CLIO unified discovery system, EBSCO Discovery Service™ (EDS) and GOBI® Library Solutions. Columbia will also utilize EBSCO's Full Text Finder, Locate and MARC Update services to streamline access, fulfillment and metadata management. The implementation further improved efficiency by connecting FOLIO to Columbia's multiple enterprise accounting systems and reducing duplicate data entry. To complement these integrations, Columbia is adopting Panorama™, EBSCO's library analytics platform, to gain real-time insights into resource usage and user engagement. These analytics will guide collection development, budget planning and user-centered service design. These technologies strengthen Columbia's foundation for scalable, open infrastructure, supporting workflows across discovery, access and analytics. Ann Thornton, Vice Provost and University Librarian, says FOLIO brings strategic value beyond the back end. "The FOLIO platform reflects Columbia Libraries' values — interoperability, openness and responsiveness to research. Equally important was our confidence in EBSCO as a trusted implementation partner. Their support enabled a smooth migration and positions us to adapt to evolving scholarly needs." Heather Macfarlane, FOLIO Implementation Manager at EBSCO, highlights the scope and teamwork involved. "Unifying Columbia's systems under FOLIO required detailed planning, customized setup and close cooperation. The outcome is a modern platform better aligned with the Libraries' shared goals and infrastructure. Columbia's team approached each stage with precision and vision, and their launch shows what's possible when the institution leads and technology supports." About EBSCO Information Services EBSCO Information Services (EBSCO) is a leading provider of online research content and cutting-edge search technologies serving libraries, healthcare and medical institutions, corporations, and government agencies worldwide. As an AI-enabled services leader, EBSCO offers comprehensive solutions from research, acquisition management, subscription services and discovery services to clinical decision support and patient care, learning, and research and development, EBSCO provides institutions with access to content and resources to serve the information and workflow needs of their users and organizations. Our commitment to AI-driven innovation positions EBSCO at the forefront of the industry, enabling us to meet the evolving needs of the information services landscape. For more information, visit the EBSCO website at: Visit our blog at EBSCOpost or follow us on X, Facebook, LinkedIn and Instagram. For more information, please contact: Erica Gilson Senior Communications Specialist egilson@ Media Contact Erica Gilson, EBSCO Information Services, 978-414-0385, egilson@ View original content: SOURCE EBSCO Information Services Sign in to access your portfolio
Yahoo
23 minutes ago
- Yahoo
‘Going To Cost Lives': Former Surgeon General Shocked By RFK's Latest Move
Robert F. Kennedy Jr.'s shock decision to cancel nearly half a billion dollars' worth of research projects because they're based on mRNA technology horrified vaccine experts Tuesday, among them President Donald Trump's own former surgeon general. Jerome Adams, who served as the nation's 20th surgeon general during Trump's first term, warned on social media that the decision will have very real negative consequences. 'I've tried to be objective & non-alarmist in response to current HHS actions – but quite frankly this move is going to cost lives,' he wrote. 'mRNA technology has uses that go far beyond vaccines… and the vaccine they helped develop in record time is credited with saving millions.' Adams ended the missive with the 'head exploding' emoji. I've tried to be objective & non-alarmist in response to current HHS actions – but quite frankly this move is going to cost lives. mRNA technology has uses that go far beyond vaccines… and the vaccine they helped develop in record time is credited with saving millions. 🤯 — Jerome Adams (@JeromeAdamsMD) August 6, 2025 In another thread, Adams blamed politicized messaging around vaccination during the coronavirus pandemic for leading to a widespread public misunderstanding of what vaccines actually accomplish. People believed that 'if you get this vaccine you won't get COVID,' said Adams, when the real aim was to prevent severe cases of the disease. Messenger RNA, or mRNA, technology has potential far beyond COVID. At Emory University, for instance, researchers are looking into using mRNA technology to train the immune system to cure cancer and chronic infections, thanks to a $24.8 million federal grant. The three-year program was funded by the Advanced Research Projects Agency for Health, or ARPA-H, which Kennedy merged with the Biomedical Advanced Research and Development Authority, or BARDA, in March — only to announce Tuesday he'd be pulling the funding for BARDA's mRNA investments. The inaugural director of ARPA-H, Dr. Renee Wegrzyn, was fired by the Trump administration in February amid mass layoffs at the Department of Health and Human Services and the Centers for Disease Control and Prevention. Tiba Biotech, another research company that saw its HHS contracts terminated Tuesday, is investigating using mRNA to combat tick-borne diseases. Thanks to climate change, more ticks are surviving through warmer winters, leading to a sharp increase in tick-borne illnesses. Mike Osterholm, a University of Minnesota expert on infectious diseases and pandemic preparations, told The Associated Press the decision on mRNA research is a historically bad one. 'I don't think I've seen a more dangerous decision in public health in my 50 years in the business,' he said. Related... RFK Jr. Cancels $500 Million In Funding For Vaccine Development 800,000 Vaccine Doses The U.S. Pledged To Send To Africa Are About To Expire Instead RFK Jr.'s Stunning Claim About Black People And Vaccines Sparks Concern From Medical Experts RFK Jr. Keeps Telling A Flat-Out Lie About Childhood Vaccines — And Doctors Are Sick Of It
Forbes
24 minutes ago
- Forbes
Founder Poaching: 3 Major Impacts On Entrepreneurs & Venture Capital
What would have happened if Gates, Bezos, and Zuckerberg had been poached mid-journey by IBM, Borders, and MySpace? These founder moves could have shaken the foundation of venture capital's most profitable model. Two billion-dollar founders have made moves that may redefine how Silicon Valley and venture capital operate. They walked away from their ventures, where they were the CEOs, in the middle of the journey. These aren't CEOs cashing out after an IPO or a strategic sale. They're visionary entrepreneurs in their prime who are leaving mid-journey to join the very tech giants they set out to disrupt. One online commentator called it 'a break in Silicon Valley's social contract.' For venture capitalists, it's more than that. It's a threat to the model that drives their returns and a sign that the old rules may be changing. Why Unicorn Founders Matter Venture capital is powered by extreme outliers. Out of 100,000 startups, only about 100 get VC funding. Of those, about 80 ventures fail, 19 are successes, and one becomes a unicorn, delivering the outsized returns that justify an entire VC fund. And that unicorn almost always hinges on the founder. In my study of 87 billion-dollar entrepreneurs, 94% succeeded because of the founder's vision and leadership, not a professional CEO hired later. Leaders like Bill Gates, Jeff Bezos, and Mark Zuckerberg attracted top-tier VCs because they'd already proven their ability to dominate emerging markets. Without these rare 'Unicorn-Entrepreneurs,' the VC model weakens. The best-performing 20–30 firms, which generate roughly 95% of U.S. VC profits, depend on just a handful of unicorns each. ( and on the founders. Do the odds change when the founders leave before a very high-valuation exit? The Major Impacts of Founder Poaching Currently, VCs replace the founder in nearly 4 out of 5 ventures, especially when the venture seeks multiple rounds of financing ( But that is under the control of the VCs and based on their analysis of the venture's needs. Now, it's the proven founders, not the VCs, who are walking away mid-journey. What would the VCs have to do to offset this new risk, especially when the VCs often invest because of the proven strategic skills and leadership potential of the Unicorn-Entrepreneur? Here are 3 likely impacts if the pattern continues: #1. Valuations Will Adjust. VCs pay a premium for founder-led unicorns because the founder's continued leadership is a key part of the growth story. If poaching becomes a trend, investors may discount valuations to account for the risk of losing that edge. #2. Deal Terms Will Tighten. Expect to see more contractual protections, designed to lock in founders, from extended vesting schedules to 'golden handcuffs' tied to milestones and profitable exits. #3. Startups Will Need New Retention Strategies Equity alone may no longer be enough. Startups may have to offer greater strategic and operational freedom, board influence, or mission-driven commitments to keep visionary founders from leaving. MY TAKE: Founder poaching isn't just a talent war story; it's a systemic risk. If leaders like Wang and Mohan can be lured away before a profitable exit, venture capital faces higher uncertainty. In Silicon Valley, ideas are plentiful. The ability to execute to build unicorns is rare. Lose those unicorn-founders, and you risk losing the ecosystem's edge.
